Verenium Corporation to Present at the Jefferies 5th Global

Clean Technology Conference 
CAMBRIDGE, Mass., May 29 /PRNewswire-FirstCall/ -- Verenium Corporation
(Nasdaq: VRNM), a leading developer of cellulosic ethanol technology and a
pioneer in the development of high-performance specialty enzymes, announced
today that John A. McCarthy, Jr., Verenium's Executive Vice President and
Chief Financial Officer, will present at the upcoming Jefferies 5th Global
Clean Technology Conference. The presentation is scheduled to begin at 10:15
a.m. ET on Thursday, June 5, and will take place in New York City. 
More information about this event, including a live webcast, may be
accessed by visiting the "Investors" section of Verenium's website at  A webcast replay will be accessible for 90 days
following the conference. 
About Verenium 
Verenium Corporation is a leader in the development and commercialization
of next-generation cellulosic ethanol, an environmentally-friendly and
renewable transportation fuel, as well as high-performance specialty enzymes
for applications within the alternative fuels, specialty industrial processes,
and animal nutrition and health markets.  The Company possesses integrated,
end-to-end capabilities in pre-treatment, novel enzyme development,
fermentation, engineering, and project development and is moving rapidly to
commercialize its proprietary technology for the production of ethanol from a
wide array of cellulosic feedstocks, including dedicated energy crops,
sugarcane bagasse, agricultural waste, and wood products.  In addition to the
vast potential for biofuels, a multitude of large-scale industrial
opportunities exist for the Company for products derived from the production
of low-cost, biomass-derived sugars. 
Verenium's Specialty Enzyme business harnesses the power of enzymes to
create a broad range of specialty products to meet high-value commercial
needs.  Verenium's world class R&D organization is renowned for its
capabilities in the rapid screening, identification, and expression of
enzymes-proteins that act as the catalysts of biochemical reactions. 
Verenium operates one of the nation's first cellulosic ethanol pilot
plants, an R&D facility, in Jennings, Louisiana and has entered the start-up
phase at its 1.4 million gallon-per-year demonstration-scale facility.  In
addition, the Company's process technology has been licensed by Tokyo-based
Marubeni Corp. and Tsukishima Kikai Co., Ltd. and has been incorporated into
BioEthanol Japan's 1.4 million liter-per-year cellulosic ethanol plant in
Osaka, Japan -- the world's first commercial-scale plant to produce cellulosic
ethanol from wood construction waste.  For more information, visit 
Forward Looking Statements 
Statements in this press release that are not strictly historical are
"forward-looking" and involve a high degree of risk and uncertainty.  These
include statements related to the Company's future growth, its expectations
for its business and operations in 2008, anticipated product volume growth and
improvement in product revenue, product gross profit and product gross margin,
startup, commissioning, testing and operation of its demonstration plant,
future commercial cellulosic ethanol projects, the impact of the Company's
2007 and 2008 accomplishments on its business in the future, the Company's
2008 corporate objectives and goals and financial guidance for the remainder
of 2008, and the Company's ability to continue to the scope of its operations
as planned, all of which are prospective.  Such statements are only
predictions, and actual events or results may differ materially from those
projected in such forward-looking statements.  Factors that could cause or
contribute to the differences include, but are not limited to, risks
associated with Verenium's new and uncertain technologies, risks associated
with the costs, labor requirements and labor availability associated with
Verenium's demonstration plant, risks associated with Verenium's ability to
obtain additional capital to support its planned operations, Verenium's
dependence on patents and proprietary rights, risks associated with Verenium's
protection and enforcement of its patents and proprietary rights,
technological, regulatory, competitive and other risks related to development,
production, and commercialization of cellulosic ethanol and other biofuels and
the commercial prospects of those industries, Verenium's dependence on
existing collaboration, manufacturing, and/or license agreements, and its
ability to achieve milestones under existing and future collaboration
agreements, the ability of Verenium and its partners to commercialize products
(including by obtaining any required regulatory approvals) using Verenium's
technologies and timing for launching any commercialized products, the ability
of Verenium and its collaborators to market and sell any products that it or
they commercialize, the development or availability of competitive products or
technologies, the future ability of Verenium to enter into and/or maintain
collaboration and joint venture agreements and licenses, changes in the U.S.
or global energy markets and risks and other uncertainties more fully
described in the Company's filings with the Securities and Exchange
Commission, including, but not limited to, the Company's quarterly report on
Form 10-Q for the three months ended March 31, 2008.  These forward-looking
statements speak only as of the date hereof.  The Company expressly disclaims
any intent or obligation to update these forward-looking statements. 

     Kelly Lindenboom
     Vice President, Corporate Communications
     Sarah Carmody
     Sr. Corporate Communications Associate

SOURCE  Verenium Corporation 
Kelly Lindenboom, Vice President, Corporate Communications, +1-617-674-5335,, or Sarah Carmody, Sr. Corporate Communications 
Associate, +1-617-674-5357,, both of Verenium 
-0- May/29/2008 12:01 GMT
Press spacebar to pause and continue. Press esc to stop.